Search for: "SANOFI-PHARMACEUTICALS, INC." Results 1 - 20 of 214
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
340B Manufacturer Notices of Correction
5 Mar 2024, 10:55 am by Evangelina Cantu
AbbVie, Inc., et al., Adventist Health System, a 340B covered entity, is suing pharmaceutical manufacturers AbbVie, AstraZeneca, Novartis, Sanofi, and Sandoz alleging that the manufacturers caused violations of the False Claims Act and various state anti-fraud laws when calculating the 340B price for drugs with price increases that outpaced inflation. [read post]
Spencer Fane Insights - https://www.spencerfane.com/insights/thought-leadership/
ISS Discusses Largest Securities-Related Class Action Settlements of 2023
23 Jan 2024, 9:01 pm by renholding
In 2022, Teva Pharmaceutical Industries Ltd. also settled shareholder allegations related to the price-fixing scheme for $420 million. 7.) [read post]
The CLS Blue Sky Blog - https://clsbluesky.law.columbia.edu/
Wachtell Lipton Discusses U.S. M&A Antitrust Enforcement for  2023 and the Year Ahead
21 Jan 2024, 9:01 pm by renholding
  In Seven & i Holdings Co., Ltd. and 7-Eleven, Inc. [read post]
The CLS Blue Sky Blog - https://clsbluesky.law.columbia.edu/
Top IP Developments of 2023
31 Dec 2023, 4:29 pm by Thomas James
Copyright Fair Use Andy Warhol Foundation for the Visual Arts, Inc. v. [read post]
Cokato Copyright Attorney - https://www.thomasbjames.com
The SCOTUS Antibody Ruling Has an Uncertain Impact for Drug Makers and Patients
20 Dec 2023, 5:00 am by Timothy Bonis
Sanofi will affect innovation and the pharmaceutical industry. [read post]
Bill of Health - https://blog.petrieflom.law.harvard.edu/
Africa IP highlights 2023: Trade marks
14 Dec 2023, 10:00 pm by Chijioke Okorie
August: In Nigeria, the French multinational pharmaceutical and healthcare company Sanofi S.A., filed a petition with the Corporate Affairs Commission (CAC) in 2019, alleging that the registration of Sanofi Integrated Services Limited, Sanofi Nigeria Enterprises Limited, and Sanofi Nigerian Enterprise was unlawful. [read post]
IPKat - http://ipkitten.blogspot.com/
Blog Post: Patent Enablement Lessons from Amgen Inc. v. Sanofi
4 Dec 2023, 10:00 pm by Sherica Celine
Sanofi , 143 S. [read post]
Legal Insights Blog - https://www.lexisnexis.com/community/insights/legal/
Sanofi-Aventis Deutschlan GMBH v. Mylan Pharmaceuticals Inc.
2 Aug 2023, 11:05 am by Sofya Asatryan
Sanofi further argued that the Board improperly shifted the burden of persuasion from Mylan to prove that the challenged claims were unpatentable to Sanofi to defend the claims of the ’614 patent as patentable. [read post]
Intellectual Property Law Blog - http://www.intellectualpropertylawblog.com/
Recitation of a Previously Unappreciated Mechanism of Action Does Not Overcome Prima Facie Obviousness of Drug Combination
15 Jun 2023, 2:20 pm by Holman
See, e.g., Sanofi-Aventis Deutschland GmbH v. [read post]
Patently-O - https://patentlyo.com
The “Inventive Step” in Analogous Prior Art
25 May 2023, 6:00 am by Brandon R. Theiss, Michael Barboun
Mylan Pharmaceuticals Inc., No. 2021-1981, 2023 U.S. [read post]
Imagine That IP Law Blog - https://www.vklaw.com/ImagineThatIPLawBlog
Supreme Court rules invalid Amgen’s patent on cholesterol-lowering drug
19 May 2023, 9:45 am by Eric M. Fraser
Justice Neil Gorsuch wrote for a unanimous court in Amgen Inc. v. [read post]
SCOTUSblog - http://www.scotusblog.com/
Amgen v. Sanofi and Regeneron: Japan IP High Court overrules its own decision on validity of Amgen patent
15 May 2023, 1:47 am by Mami Hino (Abe, Ikubo & Katayama) and Naho Ebata (Abe, Ikubo & Katayama)
On January 26, 2023, Regeneron Pharmaceuticals, Inc., who sought to invalidate Amgen Inc. [read post]
Kluwer Patent Blog - http://patentblog.kluweriplaw.com/
Supreme Court Holds Over Two Patent Cases, Considers Two More on Patent Eligibility
1 May 2023, 10:11 am by Dennis Crouch
Teva Pharmaceuticals USA, Inc. v. [read post]
Patently-O - https://patentlyo.com
Court concerned about scope of patent covering millions of antibodies
29 Mar 2023, 12:09 pm by Eric M. Fraser
ShareDuring oral argument in Amgen Inc. v. [read post]
SCOTUSblog - http://www.scotusblog.com/
Court to decide how specific a patent disclosure must be
23 Mar 2023, 11:41 am by Eric M. Fraser
In Amgen Inc. v. [read post]
SCOTUSblog - http://www.scotusblog.com/
Resurrecting the Dead: Sanofi Aventis v. HHS
7 Feb 2023, 12:00 pm by Bernard Bell
Sanofi Adventis v. [read post]
Notice & Comment - https://www.yalejreg.com/nc/
Fighting Fraud in Health Care Through the False Claims Act in the Third Circuit
5 Dec 2022, 1:03 pm by Edward T. Kang and Kandis Kovalsky
Sanofi U.S. [read post]
Kang Haggerty Firm News. - https://www.khflaw.com/news/
IPO Webinar on Enablement and Written Description
27 Nov 2022, 8:10 pm by Patent Docs
Paul Berghoff of McDonnell Boehnen Hulbert & Berghoff LLP will moderate a panel consisting of Larry Coury of Regeneron Pharmaceuticals, Inc.; Stephanie Donahue of Sanofi; Henry Hadad of Bristol-Meyers Squibb Co.; and Stuart Watt of Amgen, Inc. that will discuss the issues and arguments concerning the current state of enablement and written description law and where the law may be headed. [read post]
Patent Docs - http://www.patentdocs.org/
After Granting Certiorari In Enablement Case, Supreme Court Declines Opportunity To Address Written Description
11 Nov 2022, 9:40 am by Holman
Cir. 2021); Plexxikon Inc. v. [read post]
Patently-O - https://patentlyo.com
Supreme Court on Patent Law for October 2022
26 Sep 2022, 4:49 am by Dennis Crouch
Skinny Label Infringement in Teva Pharmaceuticals USA, Inc. v. [read post]
Patently-O - https://patentlyo.com